Related Experiment Video
Updated: Apr 16, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis
Brian Abboud1, Isra Taha2, Ziniya Shah3
1Internal Medicine, SSM Health Saint Louis University Hospital, St. Louis, Missouri, USA brian.abboud@slucare.ssmhealth.com.
Abstract:
Splanchnic vein thrombosis (SVT) is a rare, life-threatening condition that is often associated with cirrhosis, pancreatic malignancy and thrombophilia. Myeloproliferative neoplasms are under-recognised causes, posing diagnostic challenges. In this case, we present a male in his late 20s with a history of unprovoked pulmonary embolism and portal/splenic vein thrombosis, on indefinite anticoagulation therapy presenting 3 years later due to abdominal pain. Imaging revealed cirrhosis, cavernous transformation of the main portal vein and splenomegaly. These findings and a prior negative hypercoagulability workup prompted haematology consultation. Bone marrow biopsy confirmed primary myelofibrosis (PMF), demonstrating 90% cellularity, megakaryocytic hyperplasia, MF-3 fibrosis and calreticulin (CALR) mutation. This case underscores PMF as a treatable cause of SVT in young patients with recurrent thrombosis and highlights the consequences of diagnostic inertia, as marked thrombocytosis at initial presentation was overlooked. When Janus Kinase 2 (JAK2) is negative, CALR testing should be pursued to enable early diagnosis and targeted therapy.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Esophageal Varices-I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Varicose Veins I: Introduction
Venous Thrombosis IV: Nursing Management

